Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Apaziquone |
| Synonyms | |
| Therapy Description |
Apaziquone (Neoquin) is a prodrug of mitomycin C, that when converted to active metabolite, alkylate DNA and leads to apoptosis (PMID: 29034722, PMID: 31757302). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Apaziquone | Qapzola|Eoquin|Neoquin | Apaziquone (Neoquin) is a prodrug of mitomycin C, that when converted to active metabolite, alkylate DNA and leads to apoptosis (PMID: 29034722, PMID: 31757302). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03224182 | Phase III | Apaziquone | A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Patients Undergoing TURBT | Terminated | USA | 0 |